PlainPill

Lion's Mane vs Modafinil for focus

Short answer: For focus, users rate them about the same: 88% report improvement with Lion's Mane (233 reports) and 86% with Modafinil (680 reports).

Lion's Mane has 4 meta-analyses and 5 randomized trials on PubMed; Modafinil has 155 and 297.

Based on 1,182 reports about Lion's Mane and 1,595 about Modafinil. Not medical advice.

Lion's Mane
Supplement
Modafinil
Medication
User score4745
Verdict
Mixed
Mixed
Positive
of reports that state an outcome
48%50%
Reports1,1821,595
ResearchBResearch: ModerateAResearch: Strong
Meta-analyses / RCTs4 / 5155 / 297
Mainly used for
Weight loss
% reporting improvement
—100% (5)
Appetite
% reporting improvement
—33% (21)
Focus
% reporting improvement
88% (233)86% (680)
Energy
% reporting improvement
67% (43)93% (476)
Sleep
% reporting improvement
55% (29)21% (91)
Anxiety
% reporting improvement
68% (65)29% (86)
Mood
% reporting improvement
75% (124)64% (121)
Memory
% reporting improvement
92% (201)70% (30)
Performance
% reporting improvement
43% (7)81% (21)
Recovery
% reporting improvement
80% (5)—
Pain & inflammation
% reporting improvement
92% (12)—
Digestion
% reporting improvement
50% (2)—
Libido
% reporting improvement
5% (55)40% (10)
Hormones
% reporting improvement
50% (2)0% (2)
Heart & lipids
% reporting improvement
100% (2)9% (11)
Skin & hair
% reporting improvement
—50% (2)
Immunity
% reporting improvement
100% (3)—
Longevity
% reporting improvement
100% (4)—
Common side effectsanxiety, libido loss, vivid dreams, anhedoniainsomnia, anxiety, headache, tolerance
Typical dose reported900 mgas needed
Lion's Mane
Latest review conclusion

Although commonly unreported, potential side effects of HE include stomach discomfort, headache, and allergic reactions. https://www.crd.york.ac.uk/PROSPERO/view/CRD42024571250.

Front Nutr, 2025 ↗
What a user said
“Lions Mane notably lights my brain up (cognitive boost) and helps boost my mood through my typical afternoon lull.”
Full Lion's Mane profile →
Modafinil
Latest review conclusion

Our findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADHD. New research should be funded urgently to assess long-term effects of these drugs.

Lancet Psychiatry, 2018 ↗
What a user said
“It did make me focused and alert. I was working two jobs at the time and needed every ounce of energy I could muster.”
Full Modafinil profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate